Cathepsin S as a target in gastric cancer (Review)
نویسندگان
چکیده
منابع مشابه
MET amplification as a potential therapeutic target in gastric cancer
Our aim was to investigate both the prevalence of MET amplification in gastric cancer as well as the potential of this genetic alteration to serve as a therapeutic target in gastric cancer. MET amplification was assessed by initial screening with a PCR-based copy number assay followed by confirmatory FISH analysis in formalin-fixed, paraffin-embedded specimens of gastric cancer obtained at surg...
متن کاملA Mini-Review on Iron Chelating Agents as a Promising Therapeutic Target in Treatment of Leishmaniasis
There is a high prevalence of infections caused by Leishmania parasites and increasing rate of drug resistance. Lack of successful treatment with existing drugs calls for new therapeutic approaches. The main strategy in treatment of leishmaniasis is creating apoptosis and eliminating different forms of the parasite. So far, numerous drugs with specific mechanisms including 14-α-demethylase enzy...
متن کاملEvaluating the diagnostic and prognostic value of circulating cathepsin S in gastric cancer
To evaluate whether serum Cathepsin S (Cat S) could serve as a biomarker for the diagnosis and prognosis of gastric cancer (GC), Enzyme-linked immuno sorbent assay (ELISA) was used to detect serum Cat S in 496 participants including healthy controls and patients with benign gastric diseases, gastric cancer, esophageal cancer, liver cancer, colorectal cancer, nasopharyngeal cancer and lung cance...
متن کاملTarget Therapy in Gastric Cancer
Gastric cancer is the fifth most frequently diagnosed cancer and the third leading cause of cancer mortality. In advanced gastric cancer patients, the treatment outcomes are dismal. With the development of the molecular targeted therapy, the prognosis in patients with advanced and unresectable gastric cancer are improved. This article reviewed the molecular targeted agents in clinical use, thei...
متن کاملBioinformatics-Based Prediction of FUT8 as a Therapeutic Target in Estrogen Receptor-Positive Breast Cancer
Abstract Introduction: Estrogen receptor-positive (ER-positive) breast cancer is a subgroup of breast tumors that is more likely to respond to hormone therapy. ER-positive and ER- negative breast cancers tend to show different patterns of metastasis because of different signaling cascade and genes that are activated by estrogen response. Genetic factors can contribute to high rates of metastas...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Molecular and Clinical Oncology
سال: 2019
ISSN: 2049-9450,2049-9469
DOI: 10.3892/mco.2019.1958